For instance, upregulated expression of PRDM14 is positively associated with breast cancer cell growth via a reduction in their sensitivity to chemotherapeutic drugs38, while PRDM5 is epigenetically silenced in tumor tissues originating from the breast, liver, ovary, cervix, and gastrointestinal tract39,40. Here, PRDM5 is linked to neoplasm.